Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
Differential patterns of spinal cord and brain atrophy in NMO and MS.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Neurodegeneration and inflammation in MS: The eye teaches us about the storm.
Voice-related quality of life in patients with multiple sclerosis.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Immunomodulation by Transplanted Human Embryonic Stem Cell- Derived Oligodendroglial Progenitors in Experimental Autoimmune Encephalomyelitis.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
Comment on "matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis".
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Pages
« first
‹ previous
…
307
308
309
310
311
312
313
314
315
…
next ›
last »